Bevacizumab,Durvalumab,Olaparib,Carboplatin,Paclitaxel
AstraZeneca,roche,Merck
['ovarian']
 results in the treatment of advanced #ovariancancer have been welcomed by an expert not involved in the trial, even though the study showed an improvement in pfs, and not yet overall survival. #asco23 #onctwitter 
Medscape provides breaking medical news and expert perspectives, drug and disease information, and free CME across 30+ medical specialties.